Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. - Eriksson, BI; Dahl, OE; Ahnfelt, L (J Thromb Haemost, 2004)